OTC · Biotechnology

Strategic Partners A/S (OZYMF) Stock

$90.00 +0.00% OTC: OZYMF Healthcare

Initially operating as Orphazyme A/S, the company adopted its current name, Strategic Partners A/S, in October 2024. Established in 2009, this Danish entity is headquartered in Herlev.

Valuation

MetricValue
Price$90.00
Market Cap$3.72M
P/E Ratio-36.17
P/B Ratio1.69
P/S Ratio99.69
EPS (TTM)$-21.00
52-Week High$90.00
52-Week Low$0.09
Dividend Yield—

Financials & Margins

MetricValue
ROE-4.71%
ROA-4.40%
ROCE-13.30%
Gross Margin100.00%
Operating Margin-791.59%
Net Margin-277.99%
Debt/Equity0.00
Current Ratio13.90

Annual Financials (USD)

Metric20212022202320242025
Revenue$36.0M$0$0$0$0
Operating Profit$-83.0M$-41.0M$-27.0M$0$-2.0M
Net Profit$-627.0M$-111.0M$-26.0M$0$-1.0M
EPS$-2247.53$-3.14$0.00$-8.00$-21.00
Op Margin-230.6%———-791.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$173.0M$57.0M$19.0M$24.0M$20.0M
Total Liabilities$164.0M$16.0M$5.0M$4.0M$1.0M
Cash$102.0M$39.0M$11.0M$4.0M$0
Borrowings$40.0M$0$0$0$0

Latest News

Blackstone's Record Fundraising Cycle to Boost Management Fee Growth, RBC Says MT Newswires · Jul 24, 2026 Blackstone vehicle suggests even liquidity providers need liquidity solutions Pitchbook · Jun 8, 2026 Blackstone Eyes $2B Fund Stake Sale GuruFocus.com · Jun 8, 2026 Blackstone Looks to Offload $2 Billion in Private Fund Stakes GuruFocus.com · Jun 8, 2026 Ideal Power announces $30M raise to advance B-TRAN semiconductor commercialization Proactive · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-603.0M$0$0$-3.0M$-2.0M
Investing Cash Flow$-1.0M$0$-7.0M$-9.0M$-1.0M
Financing Cash Flow$-2.0M$0$-3.0M$0$0
Net Cash Flow$-625.0M$0$-28.0M$-7.0M$-3.0M
Free Cash Flow$-604.0M$0$0$-3.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-53.74%
Quick Ratio13.90
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held56.74%
Institutions Held5.86%
Institutions Float Held13.55%
Institutional HolderSharesReport Date
SPDR Portfolio Developed World ex-US ETF51,2972022-08-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
EVLOEvelo Biosciences, Inc. $0.00 — 0.00 $1898 0.00%
HLUNHEALTHeUNIVERSE, Inc. $0.00 — 0.10 $11778 0.00%
NNLXNanoLogix, Inc. $0.00 — -0.01 $9569 0.00%
PXMDPaxMedica, Inc. Common Stock $0.00 — 0.00 $88385 0.00%
QBIOQ BioMed Inc. $0.00 — 0.00 $14509 0.00%

About Strategic Partners A/S

Initially operating as Orphazyme A/S, the company adopted its current name, Strategic Partners A/S, in October 2024. Established in 2009, this Danish entity is headquartered in Herlev. Historically, its primary focus was on biotechnology; however, it presently conducts no significant business operations.

Strategic Partners A/S is headquartered in DK.

Strategic Partners A/S (OZYMF) stock trades at $90.00 with a market capitalization of $3.72M. The stock is valued at a negative price-to-earnings (P/E) ratio of -36.17, reflecting a net loss over the last twelve months, price-to-book of 1.69, price-to-sales of 99.69. Over the past 52 weeks the stock has ranged between $0.09 and $90.00, and currently trades at or near its 52-week high.

On profitability, Strategic Partners A/S generates a return on equity (ROE) of -4.71% (negative, reflecting a net loss), return on capital employed of -13.30%, an operating margin of -791.59%, a net profit margin of -277.99%.

Official website: www.strategic-partners.dk

Related Healthcare Stocks

LLY Eli Lilly and Company $1182.62 +0.28% JNJ Johnson & Johnson $263.73 +0.88% ABBV AbbVie Inc. $281.04 +1.65% MRK Merck & Company, Inc. Common Stock (new) $145.45 -0.10% UNH UnitedHealth Group Incorporated Common Stock (DE) $378.52 -0.21% NVS Novartis AG $143.84 +0.06% AZN AstraZeneca PLC $158.33 -0.55% TMO Thermo Fisher Scientific Inc $662.24 +0.64% AMGN Amgen Inc. $417.57 +0.65% GILD Gilead Sciences, Inc. $150.43 -0.49% ABT Abbott Laboratories $101.82 +2.23% NVO Novo Nordisk A/S $38.58 -0.16%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.